| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 1.085 | 39 | 1.254 | 2.321 | 6.294 | 12.604 | 8.512 | 9.510 |
| Total Income - EUR | - | 7 | 1.085 | 40 | 1.254 | 2.321 | 6.333 | 12.604 | 8.512 | 9.510 |
| Total Expenses - EUR | - | 118 | 340 | 243 | 630 | 5.917 | 2.411 | 11.179 | 8.420 | 9.340 |
| Gross Profit/Loss - EUR | - | -112 | 745 | -203 | 624 | -3.596 | 3.923 | 1.425 | 92 | 170 |
| Net Profit/Loss - EUR | - | -112 | 745 | -203 | 612 | -3.661 | 3.737 | 1.264 | 7 | 75 |
| Employees | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dinlivada Bio-Farming Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 92 | 0 | 0 | 0 | 0 | 30.206 | 31.319 | 31.224 | 33.540 |
| Current Assets | - | 64 | 1.137 | 18 | 2.427 | 2.645 | 5.270 | 4.223 | 3.269 | 3.513 |
| Inventories | - | 0 | 0 | 0 | 290 | 37 | 0 | 1.460 | 243 | 241 |
| Receivables | - | 0 | 41 | 0 | 1.517 | 1.488 | 4.286 | 0 | 0 | 0 |
| Cash | - | 64 | 1.096 | 18 | 620 | 1.119 | 985 | 2.763 | 3.026 | 3.271 |
| Shareholders Funds | - | -67 | 677 | -151 | 464 | -3.206 | 997 | 2.264 | 2.265 | 2.327 |
| Social Capital | - | 45 | 42 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 223 | 460 | 169 | 1.963 | 5.851 | 34.479 | 33.278 | 32.268 | 35.124 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8130 - 8130" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Dinlivada Bio-Farming Srl